Literature DB >> 17110690

Posterior reversible encephalopathy syndrome in infection, sepsis, and shock.

W S Bartynski1, J F Boardman, Z R Zeigler, R K Shadduck, J Lister.   

Abstract

BACKGROUND AND
PURPOSE: The cause of "posterior reversible encephalopathy syndrome" (PRES) is not established. We recently encountered several patients who developed PRES in the setting of severe infection. In this study, we comprehensively reviewed the clinical and imaging features in a large cohort of patients who developed PRES, with particular attention to those with isolated infection, sepsis, or shock (I/S/S).
METHODS: The clinical/imaging features of 106 patients who developed PRES were comprehensively evaluated. In 25 of these patients, PRES occurred in association with severe I/S/S separate from transplantation. The clinical/imaging features (computer tomography, MR imaging, and MR angiography [MRA]) of the patients with I/S/S were further evaluated, including organ/tissue/blood culture results, mean arterial blood pressure (MAP) at toxicity, extent of cerebral edema, and presence of vasospasm.
RESULTS: PRES occurred in association with I/S/S in 25 of 106 patients (23.6%), in addition to 4 other major clinical settings, including cyclosporine/FK-506 (post-transplant) neurotoxicity (46.2%), autoimmune disease (10.4%), postchemotherapy (3.7%), and eclampsia (10.4%). In the 25 patients with I/S/S, available cultures demonstrated a predominance of gram-positive organisms (84%). Blood pressure was "normal" at toxicity in 10 patients (MAP, 95 mm Hg); "severe" hypertension was present in 15 patients (MAP, 137 mm Hg). Extent of brain edema graded on imaging studies was greater in the normal MAP group compared with the severe hypertension group (P < .05). MRA demonstrated vasospasm in patients with severe hypertension and vessel "pruning" in the normal MAP group.
CONCLUSION: Infection/sepsis/shock may be an important cause of PRES, particularly in relation to infection with gram-positive organisms.

Entities:  

Mesh:

Year:  2006        PMID: 17110690      PMCID: PMC7977225     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  63 in total

1.  Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome.

Authors:  J M Provenzale; J R Petrella; L C Cruz; J C Wong; S Engelter; D P Barboriak
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

Review 2.  Etiology and pathogenesis of preeclampsia: current concepts.

Authors:  G A Dekker; B M Sibai
Journal:  Am J Obstet Gynecol       Date:  1998-11       Impact factor: 8.661

3.  Circulating endothelial cells in patients with septic shock.

Authors:  M Mutunga; B Fulton; R Bullock; A Batchelor; A Gascoigne; J I Gillespie; S V Baudouin
Journal:  Am J Respir Crit Care Med       Date:  2001-01       Impact factor: 21.405

4.  Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy.

Authors:  R B Schwartz; S K Feske; J F Polak; U DeGirolami; A Iaia; K M Beckner; S M Bravo; R A Klufas; R Y Chai; J T Repke
Journal:  Radiology       Date:  2000-11       Impact factor: 11.105

5.  Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging.

Authors:  P Mukherjee; R C McKinstry
Journal:  Radiology       Date:  2001-06       Impact factor: 11.105

6.  The epidemiology of sepsis in the United States from 1979 through 2000.

Authors:  Greg S Martin; David M Mannino; Stephanie Eaton; Marc Moss
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

7.  Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases.

Authors:  R B Schwartz; K M Jones; P Kalina; R L Bajakian; M T Mantello; B Garada; B L Holman
Journal:  AJR Am J Roentgenol       Date:  1992-08       Impact factor: 3.959

Review 8.  Nitric oxide in the pathogenesis of sepsis.

Authors:  S Symeonides; R A Balk
Journal:  Infect Dis Clin North Am       Date:  1999-06       Impact factor: 5.982

Review 9.  Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors.

Authors:  J L Ferrara
Journal:  J Hematother Stem Cell Res       Date:  2000-06

10.  Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases.

Authors:  R B Schwartz; S M Bravo; R A Klufas; L Hsu; P D Barnes; C D Robson; J H Antin
Journal:  AJR Am J Roentgenol       Date:  1995-09       Impact factor: 3.959

View more
  133 in total

1.  The posterior reversible encephalopathy syndrome in HIV infection.

Authors:  Sam Nightingale; Chris Wood; Jonathan Ainsworth
Journal:  BMJ Case Rep       Date:  2012-06-25

2.  [Acute bilateral loss of vision in posterior reversible encephalopathy syndrome].

Authors:  K S Bonsel; I Oberacher-Velten; K Hufendiek; H Jägle
Journal:  Ophthalmologe       Date:  2013-03       Impact factor: 1.059

3.  Unusual findings and diagnostic challenges in a child with Lemierre's disease.

Authors:  Florian Gahleitner; Abid M Hussain; Julian Gaskin; Andrew A Moir; Nelun Perera; James Greening
Journal:  BMJ Case Rep       Date:  2009-08-11

4.  Posterior reversible encephalopathy syndrome coexists with acute cerebral infarction: challenges of blood pressure management.

Authors:  Luji Liu; Lihong Zhang
Journal:  Quant Imaging Med Surg       Date:  2020-12

Review 5.  Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

Review 6.  Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-10       Impact factor: 3.825

7.  The heat is on: a case of hyperthermia-induced posterior reversible encephalopathy syndrome (PRES).

Authors:  Joanne L C Tan; Jason McClure; Lucy Hennington; Alexander Padiglione; Heather Cleland; Tae-Beom Ahn; Marco Fedi
Journal:  Neurol Sci       Date:  2014-01       Impact factor: 3.307

8.  Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance?

Authors:  Christina Mueller-Mang; Thomas Mang; Agnes Pirker; Katharina Klein; Christine Prchla; Daniela Prayer
Journal:  Neuroradiology       Date:  2009-02-21       Impact factor: 2.804

9.  Ciprofloxacin-associated posterior reversible encephalopathy.

Authors:  Waleed Hammad Al Bu Ali
Journal:  BMJ Case Rep       Date:  2013-04-11

10.  Imaging pattern of intracranial hemorrhage in the setting of posterior reversible encephalopathy syndrome.

Authors:  Aseem Sharma; Ryan T Whitesell; Kelsey J Moran
Journal:  Neuroradiology       Date:  2009-12-03       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.